Effect of anti-IgE therapy in patients with food allergy

Annals of Allergy, Asthma and Immunology

Volumn 91, Issue 2, 2003, Pages 119-120

  Nicklas, Richard A ^a   Chowdhury, Badrul A ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; OMALIZUMAB;

ANAPHYLAXIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; EDITORIAL; FOOD ALLERGY; HUMAN; IMMUNOTHERAPY; PEANUT ALLERGY; PRIORITY JOURNAL; SENSITIZATION; TREATMENT PLANNING;

EID: 0041737765     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62163-1     Document Type: Editorial

References (20)

1. Sampson HA, Mendelson L, Rosen HP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med. 1992;327:380-384.
2. Sampson HA. Food allergy. JAMA. 1997;278:1888-1894.
3. Skolnick HS, Conover-Walker MK, Koerner CB, Sampson HA, Burks W, Wood RA. The natural history of peanut allergy. J Allergy Clin Immunol. 2001;107:367-374.
4. Li JT, Lockey R, Bernstein IL, Portnoy JM, Nicklas RA. Allergen immunotherapy: a practice parameter. Ann Allergy Asthma Immunol. 2003;90:1-40.
5. Nelson H, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol. 1997;99:744-751.
6. Kocoshis S, Gryboski JD. Use of cromolyn in combined gastrointestinal allergy. JAMA. 1979;242:1169-1173.
7. Burks A, Sampson HA. Double-blind, placebo-controlled trial of oral cromolyn sodium in children with documented food hypersensitivity. J Allergy Clin Immunol. 1988;81:417-423.
8. Moneret-Vautrin DA, Kanny G, Parisot L. First survey from the "Allergy Vigilance Network": life-threatening food allergies in France. Allerg Immunol. 2002;34:194-198.
9. Sampson HA. Food anaphylaxis. Br Med Bull. 2000;56:925.
10. Novembre E, Cianferoni A, Bernardini R, et al. Anaphylaxis in children: clinical and allergologic features. Pediatrics. 1998; 101:E8.
11. Yocum MW, Khan DA. Assessment of patients who have experienced anaphylaxis: a 3-year survey. Mayo Clin Proc. 1994;69:16-23.
12. Kemp SF, Lockey RF, Wolf BL, Lieberman P. Anaphylaxis. A review of 266 cases. Arch Intern Med. 1995;155:1749-1754.
13. Steinman HA. "Hidden" allergens in foods. J Allergy Clin Immunol. 1996;98:241-250.
14. Cantani A. Anaphylaxis from peanut oil in infant feedings and medications. Eur Rev Med Pharmacol Sci. 1998;2:203-206.
15. Bock SA, Munoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001; 107:191-193.
16. Sampson HA. Peanut allergy. N Engl J Med. 2002;346: 1294-1299.
17. Hallet R, Haapanen LA, Teuber SS. Food allergies and kissing. N Engl J Med. 2002;346:1833-1834.
18. The use of epinephrine in the treatment of anaphylaxis. AAAI Board of Directors. J Allergy Clin Immunol. 1994;94:666-668.
19. Chang TW. Pharmacological basis of anti-IgE therapy. Nat Biotechnol. 2000;18:157-62.
20. Leung DY, Sampson HA, Yunginger JW, et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. 2003;348:986-993.